First measurement of $\bar{\nu}_{\mu}$ and $\nu_{\mu}$ charged-current inclusive interactions on water using a nuclear emulsion detector

Autor: Hiramoto, A., Suzuki, Y., Ali, A., Aoki, S., Berns, L., Fukuda, T., Hanaoka, Y., Hayato, Y., Ichikawa, A. K., Kawahara, H., Kikawa, T., Koga, T., Komatani, R., Komatsu, M., Kosakai, Y., Matsuo, T., Mikado, S., Minamino, A., Mizuno, K., Morimoto, Y., Morishima, K., Naganawa, N., Naiki, M., Nakamura, M., Nakamura, Y., Nakano, N., Nakano, T., Nakaya, T., Nishio, A., Odagawa, T., Ogawa, S., Oshima, H., Rokujo, H., Sanjana, I., Sato, O., Shibuya, H., Sugimura, K., Suzui, L., Takagi, H., Takao, T., Tanihara, Y., Yasutome, K., Yokoyama, M.

Publikováno v: Phys. Rev. D 102, 072006 (2020)

This paper reports the track multiplicity and kinematics of muons, charged pions, and protons from charged-current inclusive $\bar{\nu}_{\mu}$ and $\nu_{\mu}$ interactions on a water target, measured using a nuclear emulsion detector in the NINJA exp

Externí odkaz: http://arxiv.org/abs/2008.03895

Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis.

Autor: Kashiwagi A; Department of Diabetes and Endocrinology, Omi Medical Center, Kusatsu, Shiga, Japan., Shoji S; Medical Affairs, Astellas Pharma Inc., Tokyo, Japan., Kosakai Y; Medical Affairs, Astellas Pharma Inc., Tokyo, Japan., Yoshinaga Y; Data Science, Astellas Pharma Inc., Tokyo, Japan., Rokuda M; Medical Affairs, Astellas Pharma Inc., Tokyo, Japan.

Publikováno v: Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 374-387. Date of Electronic Publication: 2023 Dec 19.

Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study.

Autor: Watanabe K; Division of Diabetes and Metabolic Diseases, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. watanabe.kentaro@nihon-u.ac.jp., Yamaguchi S; Division of Medical Science Liaison, Department of Medical Affairs, Astellas Pharma Inc., Tokyo, Japan., Kosakai Y; Division of Medical Communications, Department of Medical Affairs, Astellas Pharma Inc., Tokyo, Japan., Ioji T; Division of Medical Statistics, Translational Research Center for Medical Innovation, Kobe, Japan., Ishihara H; Division of Diabetes and Metabolic Diseases, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2023 Dec; Vol. 43 (12), pp. 927-937. Date of Electronic Publication: 2023 Nov 07.

First measurement of ν¯μ and νμ charged-current inclusive interactions on water using a nuclear emulsion detector

Autor: Hiramoto, A., Suzuki, Y., Ali, A., Aoki, S., Berns, L., Fukuda, T., Hanaoka, Y., Hayato, Y., Ichikawa, A. K., Kawahara, H., Kikawa, T., Koga, T., Komatani, R., Komatsu, M., Kosakai, Y., Matsuo, T., Mikado, S., Minamino, A., Mizuno, K., Morimoto, Y., Morishima, K., Naganawa, N., Naiki, M., Nakamura, M., Nakamura, Y., Nakano, N., Nakano, T., Nakaya, T., Nishio, A., Odagawa, T., Ogawa, S., Oshima, H., Rokujo, H., Sanjana, I., Sato, O., Shibuya, H., Sugimura, K., Suzui, L., Takagi, H., Takao, T., Tanihara, Y., Yasutome, K., Yokoyama, M., NINJA Collaboration

Publikováno v: Physical Review D. 102(7)

This paper reports the track multiplicity and kinematics of muons, charged pions, and protons from charged-current inclusive ¯νμ and νμ interactions on a water target, measured using a nuclear emulsion detector in the NINJA experiment. A 3-kg wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=jairo_______::3c2135bbfab3920f321b6aea57cac75b
http://hdl.handle.net/2433/255617

Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis.

Autor: Abiru N; Department of Endocrinology and Metabolism, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Electronic address: jj20210239@ms.nagasaki-u.ac.jp., Shoji S; Medical Affairs, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan. Electronic address: shingo.shoji@astellas.com., Kosakai Y; Medical Affairs, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan. Electronic address: yoshinori.kosakai@astellas.com., Snijder R; Advanced Informatics & Analytics, Astellas Pharma Europe B.V, Sylviusweg 62, 2333 BE Leiden, The Netherlands. Electronic address: Robert.Snijder@astellas.com., Asakawa K; Medical Affairs, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan. Electronic address: keiko.asakawa@astellas.com., Rokuda M; Medical Affairs, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan. Electronic address: mitsuhiro.rokuda@astellas.com.

Publikováno v: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2022 Aug; Vol. 190, pp. 109973. Date of Electronic Publication: 2022 Jun 26.